Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 6/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PRMT6 | Q96LA8 | 7/20 | 0.50 |
| ▸ | PNMT | P11086 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NOS3 | P29474 | 4/20 | 0.47 |
| ▸ | NOS2 | P35228 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | HTR7 | P34969 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30125422 | 1.00 | NOS1 (0.53) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| SCHEMBL22181074 | 0.94 | CYP3A4 (0.61) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| SCHEMBL8986195 | 0.90 | PRMT6 (0.64) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| SCHEMBL1697126 | 0.89 | MAPT (0.64) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| Hydrochloric Acid SCHEMBL3273205 | 0.86 | MAPT (0.68) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| N-Benzylmethylamine SCHEMBL8215110 | 0.84 | CYP3A4 (0.74) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| Water SCHEMBL28545356 | 0.83 | LOXL2 (0.67) | NOS1CYP3A4PRMT6PNMTENPP2 | |
| N-Benzylmethylamine SCHEMBL607789 | 0.83 | MAPT (0.78) | NOS1CYP3A4KDM4EMAPTPRMT6 | |
| SCHEMBL30186883 | 0.82 | LOXL2 (0.52) | NOS1CYP3A4PRMT6PNMTENPP2 | |
| SCHEMBL834002 | 0.82 | LOXL2 (0.52) | NOS1CYP3A4PRMT6PNMTENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2796443-B1 | Curing agent for low temperature cure applications | EVONIK DEGUSSA GMBH (DE) | 2018-07-04 | — | — | EP | claimed |
| EP-2159218-B1 | Curing agent for low temperature cure applications | EVONIK DEGUSSA GMBH (DE) | 2018-06-06 | — | — | EP | claimed |
| CN-104974333-A | Curing Agent For Low Temperature Cure Applications | AIR PROD & CHEM | 2015-10-14 | — | — | CN | claimed |
| US-8512594-B2 | Curing agent of N,N′-dimethyl-meta-xylylenediamine and multifunctional amin(s) | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2013-08-20 | — | — | US | claimed |
| CN-101781397-A | Curing agents for low temperature curing applications | AIR PROD & CHEM | 2010-07-21 | — | — | CN | claimed |
| EP-2159218-A1 | Curing agent for low temperature cure applications | Air Products and Chemicals, Inc. (US) | 2010-03-03 | — | — | EP | claimed |
| US-20100048827-A1 | CURING AGENT FOR LOW TEMPERATURE CURE APPLICATIONS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2010-02-25 | — | — | US | claimed |
| EP-3642287-B1 | AQUEOUS DISPERSION OF POLYMERIC CAPSULES | AGFA GEVAERT NV (BE) | 2023-09-06 | — | — | EP | disclosed |
| US-11530226-B2 | Azepane inhibitors of menin-MLL interaction | JANSSEN PHARMACEUTICA NV (BE) | 2022-12-20 | — | — | US | disclosed |
| WO-2022118186-A1 | SENOTHERAPEUTIC COMPOUND | BIONEXA S.R.L. (IT) | 2022-06-09 | — | — | WO | disclosed |
| US-20220073699-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2022-03-10 | — | — | US | disclosed |
| US-11124593-B2 | Modified block copolymer, method for producing modified block copolymer, and resin composition | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20210230352-A1 | METHOD FOR MANUFACTURING DIISOCYANATE AND OPTICAL LENS | WOORI FINE CHEM CO., LTD. (KR) | 2021-07-29 | — | — | US | disclosed |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | IPSEN PHARMA S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC., A DELAWARE CORPORATION | 2006-02-23 | — | — | US | disclosed |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | EPIX MEDICAL, INC. A DELAWARE CORPORATION | 2005-04-07 | — | — | US | disclosed |
| EP-0558048-B1 | Thermoplastic resin composition | IDEMITSU PETROCHEMICAL CO (JP) | 1999-07-07 | — | — | EP | disclosed |
| EP-0558047-B1 | Copolymer having amino group and process for production thereof | DAI ICHI KOGYO SEIYAKU CO LTD (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5552480-A | BLEND, IMIDIZED ADDITION POLYMER, ENGINEERING PLASTIC, IMPACT STRENGTH | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1996-09-03 | — | — | US | disclosed |
| EP-0558048-A1 | Thermoplastic resin composition | IDEMITSU PETROCHEMICAL COMPANY LIMITED (JP) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060039861-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | NOS1 4334/4885CYP3A4 4876/4885KDM4E 4774/4885 |
| US-20210230352-A1 | METHOD FOR MANUFACTURING DIISOCYANATE AND OPTICAL LENS | SMO, CRYAA, INCENP | NOS1 561/4885CYP3A4 2523/4885KDM4E 2653/4885 |
| US-20050074411-A1 | Peptide-based multimeric targeted contrast agents | NGLY1, IAPP, NPPA | NOS1 4334/4885CYP3A4 4876/4885KDM4E 4774/4885 |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | SSTR2, SSTR5, SSTR3 | NOS1 3032/4885CYP3A4 973/4885KDM4E 4074/4885 |
| US-11530226-B2 | Azepane inhibitors of menin-MLL interaction | MEN1, MLLT1, BMI1 | NOS1 4550/4885CYP3A4 4491/4885KDM4E 132/4885 |
| US-20220073699-A1 | OXYGEN SCAVENGERS, COMPOSITIONS COMPRISING THE SCAVENGERS, AND ARTICLES MADE FROM THE COMPOSITIONS | PRDX5, LPO, CAT | NOS1 63/4885CYP3A4 2498/4885KDM4E 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.